<DOC>
	<DOCNO>NCT01061372</DOCNO>
	<brief_summary>The purpose study assess efficacy safety pregabalin treat moderate severe Restless Legs Syndrome comparison placebo .</brief_summary>
	<brief_title>12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome ( RLS ) Subjects</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Idiopathic Restless Legs Syndrome presence four clinical manifestation RLS : RLS symptom occur predominantly even RLS history least 6 month International Restless Legs Study Group Rating Scale ( IRLS ) great equal 15 begin end placebo runin Have great equal 15 night RLS symptom month prior screen Any secondary RLS Current augmentation due RLS treatment Placebo responder identify placebo runin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>RLS</keyword>
</DOC>